Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Patients With Poor Ovarian Response Undergoing IVF-ET, a Randomized Controlled Trial.

Trial Profile

Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Patients With Poor Ovarian Response Undergoing IVF-ET, a Randomized Controlled Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Letrozole (Primary) ; Cetrorelix; Urofollitropin
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2011 Results published in Gynecological Endocrinology.
    • 11 Jul 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 11 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top